FDA Inspection 707295 — Zafar Jamil Md

Zafar Jamil Md — FEI 3008593783

The FDA completed an inspection of Zafar Jamil Md on Jan 10, 2011 in Newark, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 7 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 10, 2011
Fiscal Year
2011
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Newark, NJ (United States)

Additional details

Clinical Investigator (CI)

Citations

IDCFRDescription
1450521 CFR 812.140(a)(3)Investigator's subject records inadequate
297421 CFR 812.110(b)Investigator non-compliance with agreement/plan/regulations
298021 CFR 812.140(a)(1)Investigator correspondence records inadequate
298221 CFR 812.140(a)(2)(ii)Investigator records of persons receiving devices inadequate
306421 CFR 812.140(a)(4)Investigator protocol records inadequate
701221 CFR 812.100Investigator lack of control of investigational devices
722721 CFR 50.27(a)Consent form not approved/signed/dated

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.